Ashok Leyland scales down production across plants as demand dips
Hinduja group flagship Ashok Leyland on Monday said it has curtailed production at its manufacturing plants due to dip in demand with second wave of COVID-19 sweeping across the country.
The company has carefully studied the demand situation, and efforts are being made to match the demand on the one hand, while being cognisant of the disruptions in the supply situation, Ashok Leyland said in a regulatory filing.
“The demand outlook for all our products is expected to be affected temporarily. Accordingly, the operations of our plants have been scaled down and are expected to work for 7-15 days in May. We will continue to respond to the COVID situation in the country as it unfolds,” it added.
At the same time, the company would continue to meet the requirement of defence vehicles and also ensure support of essential parts and aggregates for commercial vehicle portfolio, enabling movement of essential goods and services, the Chennai-based firm noted.
With a surge in COVID-19 cases across the country, various auto companies have either taken a temporary break from production for a few days or have scaled down manufacturing in order to adjust inventory with a dip in demand.
The company, which is the second largest commercial vehicle maker in the country, noted that it is committed to the wellbeing of its personnel, their families and the extended ecosystem, including customers, dealers and suppliers.
“With health and safety first as the focus, our emergency response team, a high level task force responsible for managing COVID related protocols has revisited all the standard operating procedures and is ensuring the implementation of the same,” it said.
Vaccination of employees and families is being monitored and enabled through vaccination camps across all facilities, it added.
On Monday, the daily COVID-19 cases in India showed a slight dip with 3,68,147 new coronavirus infections being reported in a day, taking the total tally of cases to 1,99,25,604.
The death toll has increased to 2,18,959 with 3,417 daily new fatalities.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
